3 -AMINO- PYRAZOLE DERIVATIVES USEFUL AGAINST TUBERCULOSIS
    2.
    发明申请
    3 -AMINO- PYRAZOLE DERIVATIVES USEFUL AGAINST TUBERCULOSIS 有权
    3-氨基吡唑衍生物应用于结核病

    公开(公告)号:US20130203802A1

    公开(公告)日:2013-08-08

    申请号:US13878889

    申请日:2011-10-11

    IPC分类号: C07D417/14 C07D471/04

    CPC分类号: C07D417/14 C07D471/04

    摘要: A compound of Formula (I) or a pharmaceutically acceptable salt thereof: Wherein: Het is a 5 to 10-membered heteroaromatic ring; Either X is N and Y is CR5; or X is C and Y is S; Z is selected from N and CH; R1 is selected from H and C1-2alkyl; R2 is selected from H, C1-2alkyl, OH, —CH2OH and C1-2alkoxy; Each R3 is independently selected from OH, C1-3alkyl, F, Cl, Br, NH2, and C1-3alkoxy; R4 is selected from C1-3alkyl and haloC1-3alkyl; R5 is selected from H, C1-3alkyl and haloC1-3alkyl; R6 and R7 are either i) each independently selected from H, C1-3alkyl and C1-3alkoxy; or ii) R6 and R7 together with the ring to which they are attached form a 9-membered bicyclic ring; p is 0-3; and RA is selected from H and C1-3alkyl, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.

    摘要翻译: 式(I)的化合物或其药学上可接受的盐:其中:Het为5至10元杂芳环; X为N,Y为CR5; 或X为C,Y为S; Z选自N和CH; R1选自H和C1-2烷基; R2选自H,C1-2烷基,OH,-CH2OH和C1-2烷氧基; 每个R 3独立地选自OH,C 1-3烷基,F,Cl,Br,NH 2和C 1-3烷氧基; R 4选自C 1-3烷基和卤代C 1-3烷基; R 5选自H,C 1-3烷基和卤代C 1-3烷基; R6和R7各自独立地选自H,C 1-3烷基和C 1-3烷氧基; 或ii)R6和R7与它们所连接的环一起形成9元双环; p为0-3; 并且RA选自H和C 1-3烷基,含有它们的组合物,它们在治疗中的用途,例如用于治疗结核病以及制备这些化合物的方法。

    3-amino-pyrazole derivatives useful against tuberculosis
    3.
    发明授权
    3-amino-pyrazole derivatives useful against tuberculosis 有权
    可用于结核病的3-氨基 - 吡唑衍生物

    公开(公告)号:US08779153B2

    公开(公告)日:2014-07-15

    申请号:US13878889

    申请日:2011-10-11

    CPC分类号: C07D417/14 C07D471/04

    摘要: A compound of Formula (I) or a pharmaceutically acceptable salt thereof: Wherein: Het is a 5 to 10-membered heteroaromatic ring; Either X is N and Y is CR5; or X is C and Y is S; Z is selected from N and CH; R1 is selected from H and C1-2alkyl; R2 is selected from H, C1-2alkyl, OH, —CH2OH and C1-2alkoxy; Each R3 is independently selected from OH, C1-3alkyl, F, Cl, Br, NH2, and C1-3alkoxy; R4 is selected from C1-3alkyl and haloC1-3alkyl; R5 is selected from H, C1-3alkyl and haloC1-3alkyl; R6 and R7 are either i) each independently selected from H, C1-3alkyl and C1-3alkoxy; or ii) R6 and R7 together with the ring to which they are attached form a 9-membered bicylic ring; p is 0-3; and RA is selected from H and C1-3alkyl, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.

    摘要翻译: 式(I)的化合物或其药学上可接受的盐:其中:Het为5至10元杂芳环; X为N,Y为CR5; 或X为C,Y为S; Z选自N和CH; R1选自H和C1-2烷基; R2选自H,C1-2烷基,OH,-CH2OH和C1-2烷氧基; 每个R 3独立地选自OH,C 1-3烷基,F,Cl,Br,NH 2和C 1-3烷氧基; R 4选自C 1-3烷基和卤代C 1-3烷基; R 5选自H,C 1-3烷基和卤代C 1-3烷基; R6和R7各自独立地选自H,C 1-3烷基和C 1-3烷氧基; 或ii)R6和R7与它们所连接的环一起形成9元双环; p为0-3; 并且RA选自H和C 1-3烷基,含有它们的组合物,它们在治疗中的用途,例如用于治疗结核病以及制备这些化合物的方法。